|Bid||62.00 x 800|
|Ask||0.00 x 900|
|Day's Range||62.27 - 63.57|
|52 Week Range||53.60 - 74.70|
|Beta (5Y Monthly)||0.51|
|PE Ratio (TTM)||20.01|
|Earnings Date||Apr 27, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||79.69|
Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.
Riding on its inorganic growth story and 2021 guidance, Centene (CNC) holds enough potential to reap benefits for investors.
Centene's (CNC) new agreement intends to improve health outcomes for eligible Medicaid and CHIP members of Hawaii.